170 related articles for article (PubMed ID: 17998914)
1. The regulation of the B-cell gene expression programme by Pax5.
Holmes ML; Pridans C; Nutt SL
Immunol Cell Biol; 2008 Jan; 86(1):47-53. PubMed ID: 17998914
[TBL] [Abstract][Full Text] [Related]
2. Pax5 maintains cellular identity by repressing gene expression throughout B cell differentiation.
Carotta S; Holmes ML; Pridans C; Nutt SL
Cell Cycle; 2006 Nov; 5(21):2452-6. PubMed ID: 17102626
[TBL] [Abstract][Full Text] [Related]
3. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1.
Souabni A; Cobaleda C; Schebesta M; Busslinger M
Immunity; 2002 Dec; 17(6):781-93. PubMed ID: 12479824
[TBL] [Abstract][Full Text] [Related]
4. Pax5: a master regulator of B cell development and leukemogenesis.
Medvedovic J; Ebert A; Tagoh H; Busslinger M
Adv Immunol; 2011; 111():179-206. PubMed ID: 21970955
[TBL] [Abstract][Full Text] [Related]
5. Identification of Pax5 target genes in early B cell differentiation.
Pridans C; Holmes ML; Polli M; Wettenhall JM; Dakic A; Corcoran LM; Smyth GK; Nutt SL
J Immunol; 2008 Feb; 180(3):1719-28. PubMed ID: 18209069
[TBL] [Abstract][Full Text] [Related]
6. Pax5: the guardian of B cell identity and function.
Cobaleda C; Schebesta A; Delogu A; Busslinger M
Nat Immunol; 2007 May; 8(5):463-70. PubMed ID: 17440452
[TBL] [Abstract][Full Text] [Related]
7. Repression of Flt3 by Pax5 is crucial for B-cell lineage commitment.
Holmes ML; Carotta S; Corcoran LM; Nutt SL
Genes Dev; 2006 Apr; 20(8):933-8. PubMed ID: 16618805
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation in early B cell development.
Fuxa M; Skok JA
Curr Opin Immunol; 2007 Apr; 19(2):129-36. PubMed ID: 17292598
[TBL] [Abstract][Full Text] [Related]
9. Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis.
Nutt SL; Eberhard D; Horcher M; Rolink AG; Busslinger M
Int Rev Immunol; 2001 Feb; 20(1):65-82. PubMed ID: 11342298
[TBL] [Abstract][Full Text] [Related]
10. Reporter gene insertions reveal a strictly B lymphoid-specific expression pattern of Pax5 in support of its B cell identity function.
Fuxa M; Busslinger M
J Immunol; 2007 Jun; 178(12):8222-8. PubMed ID: 17600970
[TBL] [Abstract][Full Text] [Related]
11. Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis.
Horcher M; Souabni A; Busslinger M
Immunity; 2001 Jun; 14(6):779-90. PubMed ID: 11420047
[TBL] [Abstract][Full Text] [Related]
12. Lymphoid Gene Upregulation on Circulating Progenitors Participates in Their T-Lineage Commitment.
Zepponi V; Michaels Lopez V; Martinez-Cingolani C; Boudil A; Pasqualetto V; Skhiri L; Gautreau L; Legrand A; Megret J; Zavala F; Ezine S
J Immunol; 2015 Jul; 195(1):156-65. PubMed ID: 26026063
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing of the trout Pax5 gene and identification of novel B cell populations using Pax5 signatures.
MacMurray E; Barr M; Bruce A; Epp L; Zwollo P
Dev Comp Immunol; 2013 Oct; 41(2):270-81. PubMed ID: 23796789
[TBL] [Abstract][Full Text] [Related]
14. B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.
Cozma D; Yu D; Hodawadekar S; Azvolinsky A; Grande S; Tobias JW; Metzgar MH; Paterson J; Erikson J; Marafioti T; Monroe JG; Atchison ML; Thomas-Tikhonenko A
J Clin Invest; 2007 Sep; 117(9):2602-10. PubMed ID: 17717600
[TBL] [Abstract][Full Text] [Related]
15. PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.
Fazio G; Palmi C; Rolink A; Biondi A; Cazzaniga G
Cancer Res; 2008 Jan; 68(1):181-9. PubMed ID: 18172310
[TBL] [Abstract][Full Text] [Related]
16. Combined heterozygous loss of Ebf1 and Pax5 allows for T-lineage conversion of B cell progenitors.
Ungerbäck J; Åhsberg J; Strid T; Somasundaram R; Sigvardsson M
J Exp Med; 2015 Jun; 212(7):1109-23. PubMed ID: 26056231
[TBL] [Abstract][Full Text] [Related]
17. The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis.
Revilla-I-Domingo R; Bilic I; Vilagos B; Tagoh H; Ebert A; Tamir IM; Smeenk L; Trupke J; Sommer A; Jaritz M; Busslinger M
EMBO J; 2012 Jun; 31(14):3130-46. PubMed ID: 22669466
[TBL] [Abstract][Full Text] [Related]
18. Context-dependent regulation of hematopoietic lineage choice by HEBAlt.
Wang D; Claus CL; Rajkumar P; Braunstein M; Moore AJ; Sigvardsson M; Anderson MK
J Immunol; 2010 Oct; 185(7):4109-17. PubMed ID: 20826759
[TBL] [Abstract][Full Text] [Related]
19. Pax5--a critical inhibitor of plasma cell fate.
Nera KP; Lassila O
Scand J Immunol; 2006 Sep; 64(3):190-9. PubMed ID: 16918686
[TBL] [Abstract][Full Text] [Related]
20. Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis.
Decker T; Pasca di Magliano M; McManus S; Sun Q; Bonifer C; Tagoh H; Busslinger M
Immunity; 2009 Apr; 30(4):508-20. PubMed ID: 19345119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
